Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026)

Enanta Pharmaceuticals (ENTA) has 13 years of Tax Rate data on file, last reported at 0.05% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate fell 550.0% year-over-year to 0.05%; the trailing twelve-month figure through Mar 2026 stood at 0.15% (down 285.0% YoY), and the FY2025 full-year result was 1.99%, up 34.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.05%, up from 0.2% in the prior quarter.
• Across five years, Tax Rate topped out at 5.45% in Q1 2025 and bottomed at 12.11% in Q2 2023.
• The 5-year median for Tax Rate is 0.63% (2022), against an average of 0.46%.
• Peak annual rise in Tax Rate reached 14521 bps in 2022, while the deepest fall reached 2670 bps in 2022.
• A 5-year view of Tax Rate shows it stood at 0.12% in 2022, then soared by 1460 bps to 1.83% in 2023, then advanced by 0 bps to 1.83% in 2024, then plunged by 111 bps to 0.2% in 2025, then soared by 73 bps to 0.05% in 2026.
• The last three Tax Rate figures came in at 0.05% (Q1 2026), 0.2% (Q4 2025), and 0.17% (Q3 2025), per Business Quant data.

Peer Comparison